Adrian T. Dillon
Known title: DirectorCIK: 0001163402
Adrian T. Dillon's purchase track record
Adrian T. Dillon has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/14/2021 | HQY | $501K | +34.4% | +70.0% | -19.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| HQY | ▲ Buy | Option Exercise | 7,632 | $248K | 8/25/2026 | View on chart |
| HQY | ▼ Sell | Open Market | 6,300 | $658K | 8/25/2026 | View on chart |
| HQY | ▼ Sell | Open Market | 1,332 | $140K | 8/25/2026 | View on chart |
| HQY | ▲ Buy | Grant | 2,877 | $0 | 6/25/2026 | View on chart |
| HQY | ▲ Buy | Grant | 2,003 | $0 | 6/26/2025 | View on chart |
| HQY | ▲ Buy | Grant | 2,543 | $0 | 7/5/2024 | View on chart |
| HQY | ▲ Buy | Grant | 1,455 | $0 | 2/1/2024 | View on chart |
| HQY | ▲ Buy | Grant | 3,164 | $0 | 6/22/2023 | View on chart |
| HQY | ▲ Buy | Grant | 2,996 | $0 | 6/23/2022 | View on chart |
| HQY | ▲ Buy | Grant | 727 | $0 | 2/1/2022 | View on chart |
| HQY | ▲ Buy | Grant | 1,819 | $0 | 2/1/2022 | View on chart |
| HQY | ▲ Buy | Open Market | 12,375 | $501K | 12/14/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
HealthEquity Appoints Moody's CFO to Board Amid AI Cash Concerns
HealthEquity has appointed Noémie Heuland, CFO of Moody's, to its board of directors. This governance move comes as market commentary highlights concerns regarding the company's cash position in the context of AI adoption. The stock is currently trading near its 52-week low, with an average analyst target price of $119.33.
HealthEquity Appoints Moody's CFO to Board Amid AI Cash Concerns. HealthEquity has appointed Noémie Heuland, CFO of Moody's, to its board of directors. This governance move comes as market commentary highlights concerns regarding the company's cash position in the context of AI adoption. The stock is currently trading near its 52-week low, with an average analyst target price of $119.33.